Skip to content

13F-HR filed by DAFNA Capital Management LLC

DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-14, with 66 holding rows worth $113,823,000.

Accession
0001389933-17-000014
Filed
2017-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2016

A holdings report, 66 entries on the cover page, a total value of $113,823,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $113,823,000 with VALUE read as thousands by filing date, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ATRICURE INC04963C209COM518,946$10,156,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK236,119$6,189,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339105COM221,013$4,597,000thousands by filing date
LOXO ONCOLOGY INC548862101COM139,722$4,487,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR66,068$4,241,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328700COM1,133,583$4,104,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock514,091$3,959,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM98,370$3,723,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR119,841$3,638,000thousands by filing date
DERMIRA INC24983L104COM98,800$2,997,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS268,067$2,976,000thousands by filing date
INSULET CORP COM45784P101Stock73,484$2,769,000thousands by filing date
APPLIED GENETIC TECHNOL CORP03820J100COM286,298$2,677,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW210,306$2,555,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM66,008$2,555,000thousands by filing date
ARDELYX INC039697107COM173,995$2,471,000thousands by filing date
INSULET CORP45784PAD3NOTE 2.000% 6/12,250,000$2,457,000thousands by filing dateprincipal
ISHARES TR464287556ISHARES BIOTECH8,700$2,309,000thousands by filing date
TESARO INC881569107COM15,500$2,084,000thousands by filing date
IMMUNOMEDICS INC452907108COM559,674$2,054,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW53,854$2,048,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM72,500$2,034,000thousands by filing date
CARA THERAPEUTICS INC140755109COM209,522$1,946,000thousands by filing date
DERMA SCIENCES INC249827502COM PAR $.01353,718$1,839,000thousands by filing date
MACROGENICS INC556099109COM89,200$1,823,000thousands by filing date
BIOTELEMETRY INC090672106COM75,000$1,676,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock159,918$1,663,000thousands by filing date
SPECTRANETICS CORP84760C107COM65,496$1,605,000thousands by filing date
Tandem Diabetes Care, Inc.875372104COM724,286$1,557,000thousands by filing date
PROTALIX BIOTHERAPEUTICS INC74365AAB7NOTE 4.500% 9/12,500,000$1,546,000thousands by filing dateprincipal
AEGLEA BIOTHERAPEUTICS INC00773J103COM350,392$1,524,000thousands by filing date
Rocket Pharmaceuticals Inc45780V102SHS237,135$1,447,000thousands by filing date
ADVAXIS INC007624208COM NEW175,000$1,253,000thousands by filing date
UNIQURE NVN90064101SHS203,907$1,142,000thousands by filing date
Johnson & Johnson478160104COM9,400$1,083,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR53,000$1,073,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM45,586$1,002,000thousands by filing date
ZOGENIX INC.98978L204Common Stock74,538$906,000thousands by filing date
STEREOTAXIS INC85916J409COMMON STOCK1,372,862$892,000thousands by filing date
EXACTECH INC30064E109COM31,636$864,000thousands by filing date
ARQULE INC04269E107COM668,735$843,000thousands by filing date
NEURODERM LTDM74231107ORD SHS37,921$842,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM196,500$812,000thousands by filing date
NOVADAQ TECHNOLOGIES INC COMMON66987G102COM101,841$722,000thousands by filing date
SYNERON MEDICAL LTDM87245102ORD85,947$722,000thousands by filing date
COGENTIX MED INC COM19243A104Stock353,482$710,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333XAD0DBCV 2.250% 6/1600,000$690,000thousands by filing dateprincipal
CONCERT PHARMACEUTICALS INC206022105COM66,968$689,000thousands by filing date
MASIMO CORP COM574795100Stock10,000$674,000thousands by filing date
INOTEK PHARMACEUTICALS CORP45780VAB8NOTE 5.750% 8/0600,000$618,000thousands by filing dateprincipal
Arbutus Biopharma Corp03879J100Common Shares, without par value234,000$573,000thousands by filing date
BLUEBIRD BIO INC09609G100COM9,000$555,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock173,645$554,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM40,192$468,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock65,900$417,000thousands by filing date
ABEONA THERAPEUTICS INC00289Y107COM76,800$372,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM223,325$314,000thousands by filing date
ESSA PHARMA INC29668H104COM98,046$289,000thousands by filing date
NEOS THERAPEUTICS INC64052L106COM38,873$227,000thousands by filing date
CELYAD ONCOLOGY SA151205200ADR12,528$222,000thousands by filing date
SPRING BK PHARMACEUTICALS IN849431101COM27,412$219,000thousands by filing date
SYNERGY PHARMACEUTICALS DEL871639308COM NEW34,000$207,000thousands by filing date
AVINGER INC053734109COM25,000$93,000thousands by filing date
GENVEC INC37246C406COM PAR9,580$31,000thousands by filing date
BIOPHARMX CORP09072X101COM77,031$29,000thousands by filing date
CHECK CAP LTDM2361E120*W EXP 02/28/20215,250$10,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001389933-17-000014this filing2017-02-14acceptance time not in the bulk data set